95 results on '"Vascular Diseases virology"'
Search Results
2. HIGH HEPARANASE LEVEL IN SURVIVORS OF COVID-19 - INDICATOR OF VASCULAR AND PULMONARY RECOVERY?
- Author
-
Neb H, Talbot SR, Ruskowski K, Brkic D, Sonntagbauer M, Adam EH, von Knethen A, Zacharowski K, and Heinicke U
- Subjects
- Humans, Cohort Studies, Enoxaparin, Heparin therapeutic use, Heparin, Low-Molecular-Weight therapeutic use, Prospective Studies, Survivors, Recovery of Function, COVID-19 Drug Treatment, COVID-19 blood, COVID-19 complications, COVID-19 diagnosis, Glucuronidase blood, Endothelium, Vascular physiopathology, Endothelium, Vascular virology, Vascular Diseases diagnosis, Vascular Diseases virology, Lung physiopathology, Lung virology
- Abstract
Abstract: Background: Severe progression of coronavirus disease 2019 (COVID-19) causes respiratory failure and critical illness. Recently, COVID-19 has been associated with heparanase (HPSE)-induced endothelial barrier dysfunction and inflammation, so called endothelitis, and therapeutic treatment with heparin or low-molecular-weight heparin (LMWH) targeting HPSE has been postulated. Because, up to this date, clinicians are unable to measure the severity of endothelitis, which can lead to multiorgan failure and concomitant death, we investigated plasma levels of HPSE and heparin-binding protein (HBP) in COVID-19 intensive care patients to render a possible link between endothelitis and these plasma parameters. Therefore, a prospective prolonged cohort study was conducted, including 47 COVID-19 patients from the intensive care unit. Plasma levels of HPSE, and HBP were measured daily by enzyme-linked immunosorbent assay in survivors (n = 35) and nonsurvivors (n = 12) of COVID-19 from admission until discharge or death. All patients were either treated with heparin or LMWH, aiming for an activated partial thromboplastin time of ≥60 seconds or an anti-Xa level of >0.8 IU/mL using enoxaparin, depending on the clinical status of the patient (patients with extracorporeal membrane oxygenation or >0.1 μg/kg/min noradrenaline received heparin, all others enoxaparin). Results: We found significantly higher plasma levels of HPSE and HBP in survivors and nonsurvivors of COVID-19, compared with healthy controls. Still, interestingly, plasma HPSE levels were significantly higher ( P < 0.001) in survivors compared with nonsurvivors of COVID-19. In contrast, plasma HBP levels were significantly reduced ( P < 0.001) in survivors compared with nonsurvivors of COVID-19. Furthermore, when patients received heparin, they had significantly lower HPSE ( P = 2.22 e - 16) and significantly higher HBP ( P = 0.00013) plasma levels as when they received LMWH. Conclusion: Our results demonstrated that patients, who recover from COVID-19-induced vascular and pulmonary damage and were discharged from the intensive care unit, have significantly higher plasma HPSE level than patients who succumb to COVID-19. Therefore, HPSE is not suitable as marker for disease severity in COVID-19 but maybe as marker for patient's recovery. In addition, patients receiving therapeutic heparin treatment displayed significantly lower heparanse plasma level than upon therapeutic treatment with LMWH., Competing Interests: The Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy of the University Hospital Frankfurt received support from B. Braun Melsungen, CSL Behring, Fresenius Kabi, and Vifor Pharma for the implementation of Frankfurt's Patient Blood Management program, and KZ received honoraria for scientific lectures and ad board meeting within the last 3 years from CSL Behring, GE Healthcare, Edwards, Haemonetics, implatcast GmbH, med Update GmbH, Pharmacosmos, and Vifor Pharma. All other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 by the Shock Society.)
- Published
- 2022
- Full Text
- View/download PDF
3. New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression.
- Author
-
Liu N, Long H, Sun J, Li H, He Y, Wang Q, Pan K, Tong Y, Wang B, Wu Q, and Gong L
- Subjects
- Adult, Aged, Aged, 80 and over, Biomarkers, Cross-Sectional Studies, Disease Progression, Endothelial Cells, Female, Humans, Male, Middle Aged, Retrospective Studies, Vascular Cell Adhesion Molecule-1, COVID-19 complications, COVID-19 diagnosis, Vascular Diseases virology
- Abstract
There is growing evidence that angiotensin-converting enzyme 2 is highly expressed on endothelial cells, endothelial dysfunction plays a critical role in coronavirus disease 2019 (COVID-19) progression, but laboratory evidence is still lacking. This study established a multicenter retrospective cohort of 966 COVID-19 patients from three hospitals in Wuhan, China. We found that male (62.8% vs. 46.5%), old age [72 (17) vs. 60.5 (21)], and coexisting chronic diseases (88.5% vs. 60.0%) were associated with poor clinical prognosis in COVID-19. Furthermore, the deteriorated patients exhibited more severe multiorgan damage, coagulation dysfunction, and extensive inflammation. Additionally, a cross-sectional study including 41 non-COVID-19 controls and 39 COVID-19 patients assayed endothelial function parameters in plasma and showed that COVID-19 patients exhibited elevated vascular cell adhesion molecule-1 (VCAM-1) (median [IQR]: 0.32 [0.27] vs. 0.17 [0.11] μg/ml, p < 0.001), E-selectin (21.06 [12.60] vs. 11.01 [4.63] ng/ml, p < 0.001), tissue-type plasminogen activator (tPA) (0.22 [0.12] vs. 0.09 [0.04] ng/ml, p < 0.001), and decreased plasminogen activator inhibitor-1 (0.75 [1.31] vs 6.20 [5.34] ng/ml, p < 0.001), as compared to normal controls. Moreover, VCAM-1 was positively correlated with d-dimer (R = 0.544, p < 0.001); tPA was positively correlated with d-dimer (R = 0.800, p < 0.001) and blood urea nitrogen (R = 0.638, p < 0.001). Our findings further confirm the strong association between endothelial dysfunction and poor prognosis of COVID-19, which offers a rationale for targeting endothelial dysfunction as a therapeutic strategy for COVID-19., (© 2022 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
4. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies.
- Author
-
Gustafson D, Ngai M, Wu R, Hou H, Schoffel AC, Erice C, Mandla S, Billia F, Wilson MD, Radisic M, Fan E, Trahtemberg U, Baker A, McIntosh C, Fan CS, Dos Santos CC, Kain KC, Hanneman K, Thavendiranathan P, Fish JE, and Howe KL
- Subjects
- Capillary Permeability, Humans, SARS-CoV-2, COVID-19 diagnosis, COVID-19 mortality, MicroRNAs metabolism, Vascular Diseases virology
- Abstract
Background: Endothelial cell (EC) activation, endotheliitis, vascular permeability, and thrombosis have been observed in patients with severe coronavirus disease 2019 (COVID-19), indicating that the vasculature is affected during the acute stages of SARS-CoV-2 infection. It remains unknown whether circulating vascular markers are sufficient to predict clinical outcomes, are unique to COVID-19, and if vascular permeability can be therapeutically targeted., Methods: Prospectively evaluating the prevalence of circulating inflammatory, cardiac, and EC activation markers as well as developing a microRNA atlas in 241 unvaccinated patients with suspected SARS-CoV-2 infection allowed for prognostic value assessment using a Random Forest model machine learning approach. Subsequent ex vivo experiments assessed EC permeability responses to patient plasma and were used to uncover modulated gene regulatory networks from which rational therapeutic design was inferred., Findings: Multiple inflammatory and EC activation biomarkers were associated with mortality in COVID-19 patients and in severity-matched SARS-CoV-2-negative patients, while dysregulation of specific microRNAs at presentation was specific for poor COVID-19-related outcomes and revealed disease-relevant pathways. Integrating the datasets using a machine learning approach further enhanced clinical risk prediction for in-hospital mortality. Exposure of ECs to COVID-19 patient plasma resulted in severity-specific gene expression responses and EC barrier dysfunction, which was ameliorated using angiopoietin-1 mimetic or recombinant Slit2-N., Interpretation: Integration of multi-omics data identified microRNA and vascular biomarkers prognostic of in-hospital mortality in COVID-19 patients and revealed that vascular stabilizing therapies should be explored as a treatment for endothelial dysfunction in COVID-19, and other severe diseases where endothelial dysfunction has a central role in pathogenesis., Funding: This work was directly supported by grant funding from the Ted Rogers Center for Heart Research, Toronto, Ontario, Canada and the Peter Munk Cardiac Center, Toronto, Ontario, Canada., Competing Interests: Declaration of interests The authors would like to disclose the following potential conflicts of interest: S.M reports personal fees from Quthero Inc.; M.R reports ownership in Quthero Inc; Quthero is working to develop QHREDGS peptides for wound healing applications and had no influence on the design, interpretation, or conclusions associated with this study. E.F. reports personal fees from ALung Technologies, Baxter, Aerogen, GE Healthcare, Inspira, and Vasomune outside the scope of the submitted work. K.H. reports personal fees from Sanofi Genzyme, Amicus, and Medscape outside the scope of the submitted work. D.G., M.R., K.K., P.T., K.H., J.E.F. and K.L.H. have submitted patents on the findings disclosed in this manuscript. All other authors declare an absence of any commercial, financial, or intellectual relationships that could be construed as a potential conflict of interest., (Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
5. Molecular mechanisms of vasculopathy and coagulopathy in COVID-19.
- Author
-
Al-Gburi S, Beissert S, and Günther C
- Subjects
- Humans, Blood Coagulation Disorders virology, Blood Coagulation Disorders metabolism, Vascular Diseases metabolism, Vascular Diseases virology, COVID-19 immunology, COVID-19 virology, COVID-19 metabolism, COVID-19 complications, SARS-CoV-2, Angiotensin-Converting Enzyme 2 metabolism
- Abstract
COVID-19 primarily affects the respiratory system and may lead to severe systemic complications, such as acute respiratory distress syndrome (ARDS), multiple organ failure, cytokine storm, and thromboembolic events. Depending on the immune status of the affected individual early disease control can be reached by a robust type-I-interferon (type-I-IFN) response restricting viral replication. If type-I-IFN upregulation is impaired, patients develop severe COVID-19 that involves profound alveolitis, endothelitis, complement activation, recruitment of immune cells, as well as immunothrombosis. In patients with proper initial disease control there can be a second flare of type-I-IFN release leading to post-COVID manifestation such as chilblain-like lesions that are characterized by thrombosis of small vessels in addition to an inflammatory infiltrate resembling lupus erythematosus (LE). Mechanistically, SARS-CoV-2 invades pneumocytes and endothelial cells by acting on angiotensin-II-converting enzyme 2 (ACE2). It is hypothesized, that viral uptake might downregulate ACE2 bioavailability and enhance angiotensin-II-derived pro-inflammatory and pro-thrombotic state. Since ACE2 is encoded on the X chromosome these conditions might also be influenced by gender-specific regulation. Taken together, SARS-CoV-2 infection affects the vascular compartment leading to variable thrombogenic or inflammatory response depending on the individual immune response status., (© 2021 Walter de Gruyter GmbH, Berlin/Boston.)
- Published
- 2021
- Full Text
- View/download PDF
6. Spontaneous right coronary artery dissection in a patient with COVID-19 infection: A case report and review of the literature.
- Author
-
Yapan Emren Z, Emren V, Özdemir E, Karagöz U, and Nazlı C
- Subjects
- Electrocardiography, Humans, Male, Middle Aged, Vascular Diseases physiopathology, Vascular Diseases therapy, Vascular Diseases virology, COVID-19 complications, Coronary Artery Disease physiopathology, Coronary Artery Disease therapy, Coronary Artery Disease virology, Coronary Vessel Anomalies physiopathology, Coronary Vessel Anomalies therapy, Coronary Vessel Anomalies virology, Vascular Diseases congenital
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the global coronavirus disease 2019 (COVID-19) pandemic. Although the virus predominantly causes respiratory system infection, recent reports have shown that it is also associated with many cardiovascular complications. It has been reported that COVID-19 may cause myocarditis, type 1 and 2 acute myocardial infarction, and thrombotic complications.[1] Spontaneous coronary artery dissection (SCAD) is a rare form of coronary artery disease that has recently been associated with COVID-19 in a few case reports. The case reported here is of COVID-19 associated SCAD in a patient with no history of cardiovascular disease.
- Published
- 2021
- Full Text
- View/download PDF
7. Regulation of NOS expression in vascular diseases.
- Author
-
Pautz A, Li H, and Kleinert H
- Subjects
- Animals, Atherosclerosis metabolism, Blood Pressure, Humans, Immunity, Innate, Inflammation, Muscle, Smooth, Vascular metabolism, Nitric Oxide chemistry, Nitric Oxide Synthase Type I metabolism, Nitric Oxide Synthase Type II metabolism, Nitric Oxide Synthase Type III metabolism, Protein Isoforms, Protein Processing, Post-Translational, RNA Processing, Post-Transcriptional, Vascular Diseases metabolism, Gene Expression Regulation, Neoplastic, Nitric Oxide Synthase metabolism, Vascular Diseases virology
- Abstract
Nitric oxide synthases (NOS) are the major sources of nitric oxide (NO), a small bioactive molecule involved in the regulation of many cellular processes. One of the most prominent functions of NO is regulation of vasodilatation and thereby control of blood pressure. Most important for vascular tone is NOS3. Endothelial NOS3-generated NO diffuses into the vascular smooth muscle cells, activates the soluble guanylate cyclase resulting in enhanced cGMP concentrations and smooth muscle cell relaxation. However, more and more evidence exist that also NOS1 and NOS2 contribute to vascular function. We summarize the current knowledge about the regulation of NOS expression in the vasculature by transcriptional, post-transcriptional and post-translational mechanisms, in regard to inflammation and innate immune pathways., (© 2021 The Author(s). Published by BRI.)
- Published
- 2021
- Full Text
- View/download PDF
8. A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications.
- Author
-
McCarthy CG, Wilczynski S, Wenceslau CF, and Webb RC
- Subjects
- Angiotensin-Converting Enzyme 2 metabolism, Animals, COVID-19 virology, Endothelium, Vascular pathology, Endothelium, Vascular virology, Host-Pathogen Interactions, Humans, Receptors, Bradykinin metabolism, Signal Transduction, Vascular Diseases pathology, Vascular Diseases virology, Bradykinin metabolism, COVID-19 complications, Endothelium, Vascular metabolism, SARS-CoV-2 pathogenicity, Vascular Diseases metabolism
- Published
- 2021
- Full Text
- View/download PDF
9. COVID Purpura (Toes) Case Series: A Chilblains-Like Vasculopathy.
- Author
-
Olsen TG, Shrit MA, Feeser TA, and Wargo JJ
- Subjects
- Adult, Chilblains pathology, Female, Humans, Male, Middle Aged, Purpura pathology, SARS-CoV-2, Vascular Diseases pathology, Young Adult, COVID-19 complications, COVID-19 pathology, Chilblains virology, Purpura virology, Toes pathology, Vascular Diseases virology
- Abstract
Abstract: Biopsies were taken from 4 patients who presented to their dermatologist with violaceous papules and plaques of the dorsal toes (COVID Toes) associated with varying degrees of severe acute respiratory syndrome coronavirus 2 exposure and COVID-19 testing. Major histopathologic findings were lymphocytic eccrine inflammation and a spectrum of vasculopathic findings to include superficial and deep angiocentric-perivascular lymphocytic inflammation, lymphocytes in vessel walls (lymphocytic vasculitis), endothelial swelling, red blood cell extravasation, and focal deposits of fibrin in both vessel lumina, and vessel walls. Interface changes were observed to include vacuolopathy and apoptotic keratinocytes at the basement membrane. Immunostains showed a dominant T-cell lineage (positive for T-cell receptor beta, CD2, CD3, CD5, and CD7). B-cells were rare and clusters of CD123-positive dermal plasmacytoid dendritic cells were observed surrounding eccrine clusters and some perivascular zones. The consistent perieccrine and vasculopathic features represent important pathologic findings in the diagnosis of COVID toes and are suggestive of pathogenetic mechanisms. Clinicopathologic correlation, the epidemiological backdrop, and the current worldwide COVID-19 pandemic favor a viral causation and should alert the physician to initiate a workup and the appropriate use of COVID-19 testing., Competing Interests: The authors declare no conflicts of interest., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
10. Severe COVID-19: A multifaceted viral vasculopathy syndrome.
- Author
-
Magro CM, Mulvey J, Kubiak J, Mikhail S, Suster D, Crowson AN, Laurence J, and Nuovo G
- Subjects
- Adult, Aged, Aged, 80 and over, Angiotensin-Converting Enzyme 2 metabolism, Autopsy, COVID-19 virology, Capsid Proteins genetics, Endothelial Cells enzymology, Endothelial Cells virology, Female, Humans, Lung physiopathology, Lung virology, Male, Microvessels physiopathology, Microvessels virology, Middle Aged, RNA, Viral genetics, SARS-CoV-2 genetics, Spike Glycoprotein, Coronavirus genetics, Thrombotic Microangiopathies virology, Vascular Diseases virology, Virion, COVID-19 physiopathology, Capsid Proteins metabolism, SARS-CoV-2 pathogenicity, Spike Glycoprotein, Coronavirus metabolism, Thrombotic Microangiopathies physiopathology, Vascular Diseases physiopathology
- Abstract
The objective of this study was to elucidate the pathophysiology that underlies severe COVID-19 by assessing the histopathology and the in situ detection of infectious SARS-CoV-2 and viral capsid proteins along with the cellular target(s) and host response from twelve autopsies. There were three key findings: 1) high copy infectious virus was limited mostly to the alveolar macrophages and endothelial cells of the septal capillaries; 2) viral spike protein without viral RNA localized to ACE2+ endothelial cells in microvessels that were most abundant in the subcutaneous fat and brain; 3) although both infectious virus and docked viral spike protein was associated with complement activation, only the endocytosed pseudovirions induced a marked up-regulation of the key COVID-19 associated proteins IL6, TNF alpha, IL1 beta, p38, IL8, and caspase 3. Importantly, this microvasculitis was associated with characteristic findings on hematoxylin and eosin examination that included endothelial degeneration and resultant basement membrane zone disruption and reduplication. It is concluded that serious COVID-19 infection has two distinct mechanisms: 1) a microangiopathy of pulmonary capillaries associated with a high infectious viral load where endothelial cell death releases pseudovirions into the circulation, and 2) the pseudovirions dock on ACE2+ endothelial cells most prevalent in the skin/subcutaneous fat and brain that activates the complement pathway/coagulation cascade resulting in a systemic procoagulant state as well as the expression of cytokines that produce the cytokine storm. The data predicts a favorable response to therapies based on either removal of circulating viral proteins and/or blunting of the endothelial-induced response., (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
11. Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID-19 infection.
- Author
-
Kumar K, Vogt JC, Divanji PH, and Cigarroa JE
- Subjects
- COVID-19 therapy, Coronary Angiography, Coronary Vessel Anomalies therapy, Electrocardiography, Female, Humans, Middle Aged, Vascular Diseases diagnosis, Vascular Diseases therapy, Vascular Diseases virology, COVID-19 complications, COVID-19 diagnosis, Coronary Vessel Anomalies diagnosis, Coronary Vessel Anomalies virology, Vascular Diseases congenital
- Abstract
A 48-year-old woman with a past medical history of migraines and hyperlipidemia presented due to severe retrosternal chest pain with no other associated signs or symptoms. The patient was hemodynamically stable and was found to have an elevated troponin with electrocardiogram showing no ischemic changes. Computed tomography of the coronary arteries showed a left dominant system with dissection extending from the mid-to-distal left anterior descending (LAD) artery. The patient was subsequently discharged on medical therapy but returned 3 days later due to worsening chest pain. Electrocardiogram revealed inferior and anteroseptal ST segment changes with peak troponin of 14.9 ng/ml (reference range <0.80 ng/ml). Coronavirus disease 2019 (COVID-19) nasopharyngeal swab was performed prior to urgent coronary angiogram. Coronary angiogram was performed with full personal protective equipment for respiratory and droplet precautions due to pending COVID-19 testing results. Angiogram revealed spontaneous coronary artery dissection (SCAD) extending from the ostium of the LAD to the distal vessel. COVID-19 testing returned positive while in intensive care unit. The patient was not a percutaneous coronary intervention candidate due to the extent of the dissection and was not a surgical candidate due to a lack of graftable target and medical management was continued. To our knowledge, this case is the first in which SCAD has been reported in the LAD in a patient with COVID-19 with no other symptoms of respiratory illness or symptoms classically associated with the novel coronavirus. SCAD should be considered on the differential as one of the various cardiac manifestations of COVID-19 infection., (© 2020 Wiley Periodicals, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
12. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
- Author
-
Kuriakose J, Montezano AC, and Touyz RM
- Subjects
- Animals, Blood Vessels enzymology, Humans, Proto-Oncogene Mas, Receptor, Angiotensin, Type 2 metabolism, Renin-Angiotensin System, SARS-CoV-2 metabolism, Vascular Diseases metabolism, Angiotensin I metabolism, Angiotensin-Converting Enzyme 2 metabolism, COVID-19 metabolism, Peptide Fragments metabolism, Proto-Oncogene Proteins metabolism, Receptors, G-Protein-Coupled metabolism, Vascular Diseases virology
- Abstract
The two axes of the renin-angiotensin system include the classical ACE/Ang II/AT1 axis and the counter-regulatory ACE2/Ang-(1-7)/Mas1 axis. ACE2 is a multifunctional monocarboxypeptidase responsible for generating Ang-(1-7) from Ang II. ACE2 is important in the vascular system where it is found in arterial and venous endothelial cells and arterial smooth muscle cells in many vascular beds. Among the best characterized functions of ACE2 is its role in regulating vascular tone. ACE2 through its effector peptide Ang-(1-7) and receptor Mas1 induces vasodilation and attenuates Ang II-induced vasoconstriction. In endothelial cells activation of the ACE2/Ang-(1-7)/Mas1 axis increases production of the vasodilator's nitric oxide and prostacyclin's and in vascular smooth muscle cells it inhibits pro-contractile and pro-inflammatory signaling. Endothelial ACE2 is cleaved by proteases, shed into the circulation and measured as soluble ACE2. Plasma ACE2 activity is increased in cardiovascular disease and may have prognostic significance in disease severity. In addition to its enzymatic function, ACE2 is the receptor for severe acute respiratory syndrome (SARS)-coronavirus (CoV) and SARS-Cov-2, which cause SARS and coronavirus disease-19 (COVID-19) respectively. ACE-2 is thus a double-edged sword: it promotes cardiovascular health while also facilitating the devastations caused by coronaviruses. COVID-19 is associated with cardiovascular disease as a risk factor and as a complication. Mechanisms linking COVID-19 and cardiovascular disease are unclear, but vascular ACE2 may be important. This review focuses on the vascular biology and (patho)physiology of ACE2 in cardiovascular health and disease and briefly discusses the role of vascular ACE2 as a potential mediator of vascular injury in COVID-19., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
13. Vascular obliteration because of endothelial and myointimal growth in COVID-19 patients.
- Author
-
Valtueña J, Martínez-García G, Ruiz-Sánchez D, Garayar-Cantero M, Dueñas C, Hadi A, Hadi S, Aguado-García Á, Prieto de Paula JM, and Manchado-López P
- Subjects
- Aged, Blood Vessels pathology, CD3 Complex metabolism, CD4 Antigens metabolism, Endothelium metabolism, Endothelium pathology, Humans, Hyperplasia pathology, Hyperplasia virology, SARS-CoV-2, Skin blood supply, Skin Diseases virology, Vascular Diseases virology, COVID-19 complications, Endothelial Cells pathology, Myocytes, Smooth Muscle pathology, Skin Diseases pathology, Vascular Diseases pathology
- Abstract
Background: Coronavirus disease 2019 (COVID-19) is a systemic multi-organ viral illness. Previous studies have found that many patients had a procoagulant state and/or severe hypoxemia with relatively well-preserved lung mechanics. Mechanisms underlying the damage to vascular tissues are not well-elucidated yet. Histological data in COVID-19 patients are still limited and are mainly focused on post-mortem analysis. Given that the skin is affected by COVID-19 and the relative ease of its histological examination, we aimed to examine the histology of skin lesions in COVID-19 patients to better understand the disease's pathology., Methods: Five skin lesions from COVID-19 adult patients were selected for a deep histological tissue examination., Results: A strong vasculopathic reaction pattern based on prominent vascular endothelial and myointimal cell growth was identified. Endothelial cell distortion generated vascular lumen obliteration and striking erythrocyte and serum extravasation. Significant deposition of C4d and C3 throughout the vascular cell wall was also identified. A regenerative epidermal hyperplasia with tissue structure preservation was also observed., Conclusions: COVID-19 could comprise an obliterative microangiopathy consisting on endothelial and myointimal growth with complement activation. This mechanism, together with the increased vascular permeability identified, could contribute to obliteration of the vascular lumen and hemorrhage in COVID-19. Thus, anticoagulation by itself could not completely reverse vascular lumen obliteration, with consequent increased risk of hemorrhage. Findings of this study could contribute to a better understanding of physiopathological mechanisms underlying COVID-19 on living patients and could help further studies find potential targets for specific therapeutic interventions in severe cases., (© 2020 the International Society of Dermatology.)
- Published
- 2021
- Full Text
- View/download PDF
14. COVID-19 - A vascular disease.
- Author
-
Siddiqi HK, Libby P, and Ridker PM
- Subjects
- Endothelium, Vascular metabolism, Endothelium, Vascular pathology, Endothelium, Vascular physiopathology, Humans, COVID-19 complications, COVID-19 therapy, SARS-CoV-2 pathogenicity, Vascular Diseases therapy, Vascular Diseases virology
- Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to multi-system dysfunction with emerging evidence suggesting that SARS-CoV-2-mediated endothelial injury is an important effector of the virus. Potential therapies that address vascular system dysfunction and its sequelae may have an important role in treating SARS-CoV-2 infection and its long-lasting effects., Competing Interests: Declaration of Competing Interest Hasan Siddiqi: No disclosures Peter Libby: Dr. Libby is an unpaid consultant to, or involved in clinical trials for Amgen, AstraZeneca, Baim Institute, Beren Therapeutics, Esperion, Therapeutics, Genentech, Kancera, Kowa Pharmaceuticals, Medimmune, Merck, Norvo Nordisk, Merck, Novartis, Pfizer, Sanofi-Regeneron. Dr. Libby is a member of scientific advisory board for Amgen, Corvidia Therapeutics, DalCor Pharmaceuticals, Kowa Pharmaceuticals, Olatec Therapeutics, Medimmune, Novartis, XBiotech, Inc. Dr. Libby's laboratory has received research funding in the last 2 years from Novartis. Dr. Libby is on the Board of Directors of XBiotech, Inc. Dr. Libby has a financial interest in Xbiotech, a company developing therapeutic human antibodies. Dr. Libby's interests were reviewed and are managed by Brigham and Women's Hospital and Partners HealthCare in accordance with their conflict of interest policies. Dr. Libby receives funding support from the National Heart, Lung, and Blood Institute (1R01HL134892), the American Heart Association (18CSA34080399), and the RRM Charitable Fund. Paul Ridker: Dr Ridker has received research grant support from Kowa, Novartis, NHLBI, NCI, and Amarin (unrelated to this manuscript) and served as a consultant to Novartis, Jansen, CiviBiopharm, Corvidia, Flame, Agepha, and Inflazome, (unrelated to this manuscript). Dr. Ridker is also part of the National Institutes of Health Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) collaborative steering committee., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
15. Spontaneous coronary artery dissection after COVID-19 infection presenting with ST segment elevation.
- Author
-
Cannata S, Birkinshaw A, Sado D, Dworakowski R, and Pareek N
- Subjects
- Coronary Angiography, Coronary Vessel Anomalies diagnostic imaging, Coronary Vessel Anomalies drug therapy, Electrocardiography, Female, Humans, Middle Aged, Troponin T blood, Vascular Diseases diagnostic imaging, Vascular Diseases drug therapy, Vascular Diseases virology, Ventricular Dysfunction, Left diagnostic imaging, Ventricular Dysfunction, Left drug therapy, Antibodies, Viral blood, COVID-19 complications, Coronary Vessel Anomalies virology, SARS-CoV-2 immunology, Vascular Diseases congenital
- Published
- 2020
- Full Text
- View/download PDF
16. Vascular Endothelial Glycocalyx Damage in COVID-19.
- Author
-
Yamaoka-Tojo M
- Subjects
- Endothelial Cells pathology, Humans, Lung pathology, Lung virology, Prognosis, SARS-CoV-2, Vascular Diseases virology, COVID-19 pathology, Endothelium, Vascular pathology, Glycocalyx pathology, Vascular Diseases pathology
- Abstract
The new coronavirus disease-2019 (COVID-19), which is spreading around the world and threatening people, is easily infecting a large number of people through airborne droplets; moreover, patients with hypertension, diabetes, obesity, and cardiovascular disease are more likely to experience severe conditions. Vascular endothelial dysfunction has been suggested as a common feature of high-risk patients prone to severe COVID-19, and measurement of vascular endothelial function may be recommended for predicting severe conditions in high-risk patients with COVID-19. However, fragmented vascular endothelial glycocalyx (VEGLX) is elevated in COVID-19 patients, suggesting that it may be useful as a prognostic indicator. Although the relationship between VEGLX and severe acute respiratory syndrome coronavirus 2 infections has not been well studied, some investigations into COVID-19 have clarified the relationship between VEGLX and the mechanism that leads to severe conditions. Clarifying the usefulness of VEGLX assessment as a predictive indicator of the development of severe complications is important as a strategy for confronting pandemics caused by new viruses with a high affinity for the vascular endothelium that may recur in the future.
- Published
- 2020
- Full Text
- View/download PDF
17. Post-COVID-19 Syndrome (PC19S): Chronic Reactive Endotheliitis and Disseminated Vascular Disease.
- Author
-
López Castro J
- Subjects
- COVID-19 pathology, Humans, Post-Acute COVID-19 Syndrome, COVID-19 complications, Endothelium, Vascular pathology, Inflammation virology, Vascular Diseases virology
- Published
- 2020
- Full Text
- View/download PDF
18. Noninvasive detection of impaired pulmonary artery endothelial function in people living with HIV.
- Author
-
Goerlich E, Mukherjee M, Schar M, Brown TT, Bonanno G, Weiss RG, and Hays AG
- Subjects
- Endothelium, Vascular diagnostic imaging, Endothelium, Vascular physiopathology, Female, Hand Strength, Humans, Male, Middle Aged, Prospective Studies, HIV Infections diagnostic imaging, HIV Infections physiopathology, Pulmonary Artery diagnostic imaging, Pulmonary Artery physiopathology, Vascular Diseases diagnostic imaging, Vascular Diseases physiopathology, Vascular Diseases virology
- Abstract
Objective: People living with HIV (PLWH) have an increased risk of pulmonary vascular disease and pulmonary hypertension. Endothelial cell dysfunction is thought to contribute, but human studies have been limited by the invasive nature of conventional measures of pulmonary artery endothelial function (PAEF). We report here a noninvasive MRI approach to measure nitric oxide mediated PAEF by quantifying changes in pulmonary artery area and blood flow during isometric handgrip exercise (IHE), an endothelial nitric oxide dependent stressor. We used this to test the hypothesis that PLWH have impaired PAEF, even before development of pulmonary hypertension., Design: A prospective cohort study., Methods: We enrolled 25 HIV-positive viral-suppressed individuals on stable antiretroviral therapy without known or suspected pulmonary hypertension and 19 matched seronegative control individuals (HIV-negative). Pulmonary artery area and blood flow changes in response to IHE were measured with noncontrast MRI. Data previously collected during nitric oxide-synthase inhibition were analysed to determine the role of nitric oxide in the pulmonary artery response to IHE., Results: Seronegative individuals exhibited the anticipated PA vasodilatory response to IHE, but this was completely absent in HIV-positive individuals who exhibited an impaired area change (-1.1 ± 1.2 vs. +7.7 ± 2.2%, HIV-positive vs. HIV-negative, mean ± SEM, respectively, P = 0.002) and blood flow response (0.2 ± 2.3 vs. 13.5 ± 4.8%, P = 0.005). The pulmonary artery vasodilatory effect of IHE in healthy individuals was fully blocked by nitric oxide-synthase, demonstrating this pulmonary artery response is predominantly nitric oxide mediated., Conclusion: Using noninvasive MRI methods to quantify PAEF, we observed significantly impaired PAEF in PLWH compared with matched HIV-negative controls. Noninvasive PAEF testing may be useful in evaluating early HIV-related pulmonary vascular disease.
- Published
- 2020
- Full Text
- View/download PDF
19. Reply to Jounieaux et al. : On Happy Hypoxia and on Sadly Ignored "Acute Vascular Distress Syndrome" in Patients with COVID-19.
- Author
-
Tobin MJ, Laghi F, and Jubran A
- Subjects
- Humans, Hypoxia, Pandemics, SARS-CoV-2, COVID-19 complications, Respiratory Distress Syndrome, Vascular Diseases virology
- Published
- 2020
- Full Text
- View/download PDF
20. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
- Author
-
Kumar A, Narayan RK, Kumari C, Faiq MA, Kulandhasamy M, Kant K, and Pareek V
- Subjects
- COVID-19 pathology, Endothelium, Vascular pathology, Humans, Recombinant Proteins metabolism, Serine Endopeptidases metabolism, Signal Transduction, Thrombosis metabolism, Treatment Outcome, Vascular Diseases metabolism, Virus Internalization, Angiotensin-Converting Enzyme 2 metabolism, COVID-19 complications, Endothelium, Vascular metabolism, SARS-CoV-2 physiology, Thrombosis virology, Vascular Diseases virology
- Abstract
Several studies have described unusually high incidence of vascular thrombosis in coronavirus disease-2019 (COVID-19) patients. Pathogenesis of the vascular thrombosis in COVID-19 is least understood for now and presents a challenge to the treating physicians. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative pathogen for COVID-19, has been shown to bind to angiotensin converting enzyme 2 (ACE2) protein in human epithelial cells which facilitates its entry in the organ and mediate tissue specific pathogenesis. For ACE2 mediated cell entry of the SARS-CoV-2, co-expression of one more protein-Transmembrane protease serine 2 (TMPRSS2) is essential. Existing studies suggested significant expression of ACE2 and TMPRSS2 in human vascular endothelium. Vascular endothelial dysfunction can potentially activate coagulation cascade eventually resulting in thrombosis. ACE2 has proven role in the maintenance of endothelial integrity inside the vessels. Existing in situ evidence for SARS-CoV-1 (the causative agent for SARS pandemic of 2002, which shared ACE2 as cell entry receptor) suggested that virus binding can downregulate ACE2, thus can induce endothelial dysfunction. Recently, in situ evidence has been presented that SARS-CoV-2 can infect cells in engineered human vascular endothelium, which can be effectively blocked by using clinical-grade recombinant human ACE2. Based on the circumstantial evidence present in the literature, we propose a SARS-CoV-2 cell entry receptor ACE2 based mechanism for vascular thrombosis in COVID-19 patients., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
21. Extrapulmonary SARS-CoV-2 manifestations.
- Author
-
Carvalho T
- Subjects
- Autopsy, Blood Coagulation Disorders mortality, Blood Coagulation Disorders virology, COVID-19 epidemiology, COVID-19 mortality, Cause of Death, Humans, Pandemics, Pulmonary Embolism mortality, Pulmonary Embolism virology, RNA, Viral blood, Respiratory System pathology, Respiratory System virology, SARS-CoV-2 pathogenicity, SARS-CoV-2 physiology, Vascular Diseases mortality, Venous Thrombosis mortality, Venous Thrombosis virology, COVID-19 complications, COVID-19 pathology, Vascular Diseases virology
- Published
- 2020
- Full Text
- View/download PDF
22. COVID-19, neutrophil extracellular traps and vascular complications in obstetric practice.
- Author
-
Makatsariya A, Slukhanchuk E, Bitsadze V, Khizroeva J, Tretyakova M, Tsibizova V, Dobryakov A, Elalamy I, and Gris JC
- Subjects
- Angiotensin-Converting Enzyme 2, COVID-19, Comorbidity, Coronavirus Infections drug therapy, Coronavirus Infections epidemiology, Delivery, Obstetric methods, Female, Heparin, Low-Molecular-Weight therapeutic use, Humans, Lung virology, Pandemics, Peptidyl-Dipeptidase A metabolism, Pneumonia, Viral drug therapy, Pneumonia, Viral epidemiology, Pregnancy, Pregnancy Complications, Infectious drug therapy, Pregnancy Complications, Infectious physiopathology, Risk Factors, SARS-CoV-2, Vascular Diseases epidemiology, Vascular Diseases prevention & control, Betacoronavirus, Coronavirus Infections complications, Extracellular Traps physiology, Neutrophils ultrastructure, Pneumonia, Viral complications, Pregnancy Complications, Infectious virology, Vascular Diseases virology
- Abstract
An issue of the novel coronavirus infection spreading is currently in the first place among others in the list of the international medical community. Due to lack of information, conflicting research findings, multicomponent effect of the virus on the body host, as well as various consequences that the virus triggers in the body, now every medical specialty does study the viral attack pathogenesis. Recent months showed that vascular complications are the most severe in the Coronavirus Disease 2019 (COVID-19) and are the main cause of death in the patients. The mechanisms of vascular complications are complex and affect both the hemostatic system and immune responses, "inflammatory storm", disorders of the renin-angiotensin-aldosterone system, endotheliopathy, etc. Due to the leading role of vascular complications in the viral infection pathogenesis, several groups of patients are at extra risk, including pregnant women, patients with a burdened obstetric history, with hereditary thrombophilia and antiphospholipid syndrome, and patients after in vitro fertilization (IVF). In this category of pregnant women, use of low-molecular-weight heparins (LMWH) is particularly important for both prevention of vascular and obstetric complications, and for pathogenetic therapy of COVID-19.
- Published
- 2020
- Full Text
- View/download PDF
23. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities.
- Author
-
Falasca L, Nardacci R, Colombo D, Lalle E, Di Caro A, Nicastri E, Antinori A, Petrosillo N, Marchioni L, Biava G, D'Offizi G, Palmieri F, Goletti D, Zumla A, Ippolito G, Piacentini M, and Del Nonno F
- Subjects
- Adult, Aged, Aged, 80 and over, Autopsy methods, Bone Marrow pathology, COVID-19 epidemiology, COVID-19 virology, Comorbidity, Female, Humans, Italy epidemiology, Kidney pathology, Liver pathology, Lung pathology, Male, Middle Aged, Spleen pathology, Thrombosis pathology, Vascular Diseases pathology, Vascular Diseases virology, COVID-19 pathology
- Abstract
Background: Descriptions of the pathological features of coronavirus disease-2019 (COVID-19) caused by the novel zoonotic pathogen severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emanate from tissue biopsies, case reports, and small postmortem studies restricted to the lung and specific organs. Whole-body autopsy studies of COVID-19 patients have been sparse., Methods: To further define the pathology caused by SARS-CoV-2 across all body organs, we performed autopsies on 22 patients with COVID-19 (18 with comorbidities and 4 without comorbidities) who died at the National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS Hospital, Rome, Italy. Tissues from the lung, heart, liver, kidney, spleen, and bone marrow (but not the brain) were examined. Only lung tissues were subject to transmission electron microscopy., Results: COVID-19 caused multisystem pathology. Pulmonary and cardiovascular involvement were dominant pathological features. Extrapulmonary manifestations included hepatic, kidney, splenic, and bone marrow involvement, and microvascular injury and thrombosis were also detected. These findings were similar in patients with or without preexisting medical comorbidities., Conclusions: SARS-CoV-2 infection causes multisystem disease and significant pathology in most organs in patients with and without comorbidities., (© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.)
- Published
- 2020
- Full Text
- View/download PDF
24. Non-invasive assessment of endothelial dysfunction: A novel method to predict severe COVID-19?
- Author
-
Yoganandamoorthy S, Munasinghe MADSN, Wanigasuriya LVU, Priyankara MKK, and Jayasinghe S
- Subjects
- COVID-19 complications, COVID-19 epidemiology, Cardiovascular Diseases, Cytokines metabolism, Female, Humans, Immune System, Male, Nitric Oxide metabolism, Prognosis, Risk, Treatment Outcome, Vascular Diseases epidemiology, Vascular Diseases virology, COVID-19 Drug Treatment, COVID-19 diagnosis, COVID-19 Testing, Comorbidity, Endothelium, Vascular pathology, Vascular Diseases diagnosis
- Abstract
The COVID-19 pandemic caused by the SARS-CoV-2 virus has infected millions and overburdened the healthcare infrastructure globally. Recent studies show that the endothelial dysfunction caused by the virus contributes to its high morbidity and mortality. A parameter that can identify patients who will develop complications early will be valuable in patient management and reducing the burden on medical resources. An emerging technology is currently being tested to predict the cardiovascular risk via non-invasively measuring the endothelial dysfunction. This paper reviews how the assessment of endothelial dysfunction using this technology can be used as a potential parameter in the prognostication and management of COVID-19 patients., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. Covid-19 pneumonia and pulmonary vascular disease: A UK Centre perspective.
- Author
-
John Wort S, Arachchillage DJ, McCabe C, and Price LC
- Subjects
- COVID-19 epidemiology, COVID-19 therapy, Critical Care methods, Critical Care standards, Extracorporeal Membrane Oxygenation methods, Extracorporeal Membrane Oxygenation standards, Humans, Hypertension, Pulmonary epidemiology, Hypertension, Pulmonary therapy, Hypertension, Pulmonary virology, Lung Diseases epidemiology, Lung Diseases therapy, Pandemics, Pneumonia, Viral epidemiology, Pneumonia, Viral therapy, Practice Guidelines as Topic, Pulmonary Embolism epidemiology, Pulmonary Embolism therapy, Pulmonary Embolism virology, Pulmonary Veno-Occlusive Disease epidemiology, Pulmonary Veno-Occlusive Disease etiology, Pulmonary Veno-Occlusive Disease therapy, SARS-CoV-2 physiology, United Kingdom epidemiology, Vascular Diseases epidemiology, Vascular Diseases therapy, COVID-19 complications, Lung Diseases virology, Pneumonia, Viral complications, Vascular Diseases virology
- Published
- 2020
- Full Text
- View/download PDF
26. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
- Author
-
Mondal R, Lahiri D, Deb S, Bandyopadhyay D, Shome G, Sarkar S, Paria SR, Thakurta TG, Singla P, and Biswas SC
- Subjects
- Animals, Betacoronavirus genetics, Betacoronavirus immunology, Blood Coagulation, Blood Vessels immunology, Blood Vessels metabolism, Blood Vessels physiopathology, COVID-19, Coronavirus Infections immunology, Coronavirus Infections metabolism, Coronavirus Infections physiopathology, Cytokines metabolism, Hemodynamics, Host-Pathogen Interactions, Humans, Inflammation Mediators metabolism, Pandemics, Phylogeny, Pneumonia, Viral immunology, Pneumonia, Viral metabolism, Pneumonia, Viral physiopathology, Prognosis, Risk Assessment, Risk Factors, SARS-CoV-2, Vascular Diseases immunology, Vascular Diseases metabolism, Vascular Diseases physiopathology, Betacoronavirus pathogenicity, Blood Vessels virology, Coronavirus Infections virology, Pneumonia, Viral virology, Vascular Diseases virology
- Abstract
After the emergence of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in the last two decades, the world is facing its new challenge in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic with unprecedented global response. With the expanding domain of presentations in COVID-19 patients, the full range of manifestations is yet to unfold. The classical clinical symptoms for SARS-CoV-2 affected patients are dry cough, high fever, dyspnoea, lethal pneumonia whereas many patients have also been found to be associated with a few additional signs and clinical manifestations of isolated vasculopathy. Albeit a deep and profound knowledge has been gained on the clinical features and management of COVID-19, less clear association has been provided on SARS-CoV-2 mediated direct or indirect vasculopathy and its possible correlation with disease prognosis. The accumulative evidences suggest that novel coronavirus, apart from its primary respiratory confinement, may also invade vascular endothelial cells of several systems including cerebral, cardio-pulmonary as well as renal microvasculature, modulating multiple visceral perfusion indices. Here we analyse the phylogenetic perspective of SARS-CoV-2 along with other strains of β-coronaviridae from a standpoint of vasculopathic derangements. Based on the existing case reports, literature and open data bases, we also analyse the differential pattern of vasculopathy related changes in COVID-19 positive patients. Besides, we debate the need of modulation in clinical approach from a hemodynamical point of view, as a measure towards reducing disease transmission, morbidity and mortality in SARS-CoV-2 affected patients.
- Published
- 2020
- Full Text
- View/download PDF
27. COVID-19 and the pulmonary vascular injury.
- Author
-
Dai HL and Guang XF
- Subjects
- Angiotensin-Converting Enzyme 2, Animals, COVID-19, Endothelium, Vascular enzymology, Humans, Pandemics, Peptidyl-Dipeptidase A metabolism, Renin-Angiotensin System physiology, SARS-CoV-2, Betacoronavirus physiology, Coronavirus Infections complications, Pneumonia, Viral complications, Vascular Diseases virology
- Published
- 2020
- Full Text
- View/download PDF
28. An interesting case of small vessel pathology following coronavirus infection.
- Author
-
Ramadan SM, Kasfiki EV, Kelly CW, and Ali I
- Subjects
- COVID-19, Female, Humans, Middle Aged, Pandemics, Coronavirus Infections complications, Pneumonia, Viral complications, Vascular Diseases virology
- Abstract
Vasculitis is a descriptive term for a wide variety of conditions characterised by inflammation of the blood vessels that may occur as a primary process or secondary to an underlying disease. Occlusive vasculopathy is a different clinical entity characterised by skin changes and ulceration of the lower extremities because of thrombosis of the small vessels of the dermis and is usually associated with pre-thrombotic conditions. Both conditions can be confirmed or excluded by skin biopsy. We report the case of a 63-year-old woman presenting with upper and lower respiratory tract symptoms followed by a vasculitic rash on both legs. The patient underwent extensive radiological and laboratory investigations that were negative apart from positive coronavirus OC43. A biopsy of the skin was performed. Considering the clinical presentation and the investigations performed, the diagnosis of small vessel vasculopathy following coronavirus OC43 has been suggested by the authors., Competing Interests: Competing interests: None declared., (© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2020
- Full Text
- View/download PDF
29. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction.
- Author
-
Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, Frank S, Turek D, Willi N, Pargger H, Bassetti S, Leuppi JD, Cathomas G, Tolnay M, Mertz KD, and Tzankov A
- Subjects
- Aged, Aged, 80 and over, Autopsy, Capillaries virology, Female, Humans, Lung pathology, Male, Middle Aged, SARS-CoV-2, COVID-19 pathology, Capillaries pathology, Vascular Diseases pathology, Vascular Diseases virology
- Abstract
Aims: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly evolved into a sweeping pandemic. Its major manifestation is in the respiratory tract, and the general extent of organ involvement and the microscopic changes in the lungs remain insufficiently characterised. Autopsies are essential to elucidate COVID-19-associated organ alterations., Methods and Results: This article reports the autopsy findings of 21 COVID-19 patients hospitalised at the University Hospital Basel and at the Cantonal Hospital Baselland, Switzerland. An in-corpore technique was performed to ensure optimal staff safety. The primary cause of death was respiratory failure with exudative diffuse alveolar damage and massive capillary congestion, often accompanied by microthrombi despite anticoagulation. Ten cases showed superimposed bronchopneumonia. Further findings included pulmonary embolism (n = 4), alveolar haemorrhage (n = 3), and vasculitis (n = 1). Pathologies in other organ systems were predominantly attributable to shock; three patients showed signs of generalised and five of pulmonary thrombotic microangiopathy. Six patients were diagnosed with senile cardiac amyloidosis upon autopsy. Most patients suffered from one or more comorbidities (hypertension, obesity, cardiovascular diseases, and diabetes mellitus). Additionally, there was an overall predominance of males and individuals with blood group A (81% and 65%, respectively). All relevant histological slides are linked as open-source scans in supplementary files., Conclusions: This study provides an overview of postmortem findings in COVID-19 cases, implying that hypertensive, elderly, obese, male individuals with severe cardiovascular comorbidities as well as those with blood group A may have a lower threshold of tolerance for COVID-19. This provides a pathophysiological explanation for higher mortality rates among these patients., (© 2020 The Authors. Histopathology published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
30. Underexpression of endothelial nitric oxide synthase leads to more severe pulmonary complex vascular lesions associated with HIV patients.
- Author
-
Sandoval-Gutiérrez JL, Almodovar S, Rivera-Morales RM, and Rodríguez-Silverio J
- Subjects
- Adult, Female, Humans, Male, Middle Aged, Pulmonary Artery physiopathology, Severity of Illness Index, Vascular Diseases enzymology, Vascular Diseases virology, Young Adult, HIV Infections complications, Nitric Oxide metabolism, Nitric Oxide Synthase Type III metabolism, Vascular Diseases physiopathology
- Abstract
Background: Despite increase in survival of human immunodeficiency virus (HIV) patients due to highly active antiretroviral therapy, non-infectious complications are still prevalent such as presentation of lung vasculopathy, even in asymptomatic patients. Endothelial nitric oxide synthase (eNOS) is necessary to produce nitric oxide that causes pulmonary endothelial vasodilation. Participation of this protein in the pulmonary circulation in HIV patients has not been elucidated. This work studied the presence and expression of eNOS in pulmonary complex vascular lesions associated with HIV (PCVL/HIV)., Methods: In lung tissues from patients who died from complications of HIV, we used immunohistochemistry and immune chemiluminescence (imageJ) to determine the different degrees of expression of eNOS in PCVL-HIV in comparison with non-PCVL/HIV. Reagents used were anti-eNOS and an automated system. All data are presented as mean and standard deviation. Differences were analyzed with Wilcoxon; p < 0.05 was accepted as statistically significant., Results: In 57 tissues, the histological evidence of pulmonary vasculopathy was showed as different types (proliferative, obliterative, and plexiform) and severe presentation of vasculopathy than non-PCVL/HIV. A statistically significant decrease of eNOS was observed in all PCVL/HIV tissue samples., Conclusion: eNOS has a relevant role in the pathogenesis of pulmonary vasculopathy in acquired immunodeficiency syndrome patients. It is necessary to determine in the future the participation of eNOS and other mechanisms involved in PCVL/HIV., (Copyright: © 2020 Permanyer.)
- Published
- 2020
- Full Text
- View/download PDF
31. COVID-19, Vascular Diseases, and Vascular Services.
- Author
-
Puech-Leão P, César LAM, and De Luccia N
- Subjects
- COVID-19, Humans, SARS-CoV-2, Vascular Diseases therapy, Betacoronavirus, Cardiology Service, Hospital organization & administration, Coronavirus Infections complications, Pandemics, Pneumonia, Viral complications, Vascular Diseases virology
- Published
- 2020
- Full Text
- View/download PDF
32. Coronavirus Disease and Acute Vascular Events.
- Author
-
Rao GHR
- Subjects
- Acute Disease, Betacoronavirus isolation & purification, COVID-19, Coronavirus Infections virology, Humans, Pandemics, Pneumonia, Viral virology, SARS-CoV-2, Vascular Diseases pathology, Coronavirus Infections pathology, Pneumonia, Viral pathology, Vascular Diseases virology
- Published
- 2020
- Full Text
- View/download PDF
33. Varicella zoster virus reactivation antedating ipsilateral brainstem stroke.
- Author
-
Galassi G, Genovese M, Meacci M, and Malagoli M
- Subjects
- Acyclovir therapeutic use, Aged, Antibodies, Viral blood, Antiviral Agents therapeutic use, Brain Stem Infarctions etiology, Brain Stem Infarctions virology, Female, Herpes Zoster Ophthalmicus blood, Herpes Zoster Ophthalmicus complications, Herpes Zoster Ophthalmicus drug therapy, Herpesvirus 3, Human immunology, Humans, Magnetic Resonance Imaging, Male, Pons blood supply, Vascular Diseases etiology, Vascular Diseases virology, Virus Activation, Brain Stem Infarctions diagnosis, Herpes Zoster Ophthalmicus diagnosis, Pons diagnostic imaging, Vascular Diseases diagnosis
- Abstract
itor Title: Varicella zoster virus reactivation antedating ipsilateral brainstem stroke Authors: Giuliana Galassi1, Maurilio Genovese2, Marisa Meacci3, Marcella Malagoli2 Affiliations: 1Department of Biomedical, Metabolic, Neural Sciences, University Hospital of Modena, Italy, 2Neuroradiology Service, University Hospital of Modena, Italy, 3Department of Laboratory Medicine and Patholgy, Microbiology and Virology Unit, University Hospital of Modena, Italy Corresponding Author: Giuliana Galassi, MD, Department of Biomedical, Metabolic, Neural Sciences, University Hospital of Modena, Via P. Giardini 1455, Modena, Italy, Tel: 39-3497325802, Email: giulianagalassi46@gmail.com Abstract: Varicella zoster virus (VZV) infection and reactivation are associated with a number of neurologic conditions. Unifocal large vessel infarcts may follow zoster in the trigeminal or cervical distribution as a result of transaxonal transport of virus from trigeminal or cervical afferent fibers that innervate vessels. Ophthalmic zoster (HZO) might cause ophthalmoplegic syndromes, with secondary optic neuritis. Mechanisms include local orbital muscle inflammation and, viral spread from the ophthalmic branch of the fifth nerve with associated vasculopathy. A 72-year-old man developed a vesicular rash in the territory of C5-T5-6. Within four weeks, the patient developed headache, dysphagia, left facial and extremity ataxic weakness. Magnetic resonance imaging (MRI) revealed a right pontine infarction. A 66-year-old woman presented with right-sided painfull HZO. One week later she developed complete external ophthalmoplegia and blurred vision. MRI showed ill-defined signal alteration in the retrobulbar tissue. Three weeks later, the patient was admitted because of dysarthria, deviated tongue, left-sided limb weakness, and tactile hypoesthesia. Spinal fluid contained 23 lymphocytes/mm3 and increased protein. The serum contained antibodies to VZV IgG and IgM in both cases. The patients received intravenously acyclovir with improvement. This report confirms unusual occurrence of ipsilateral brainstem stroke after VZV reactivation in immunocompetent subjects.
- Published
- 2018
34. Longitudinal study of Senecavirus a shedding in sows and piglets on a single United States farm during an outbreak of vesicular disease.
- Author
-
Tousignant SJP, Bruner L, Schwartz J, Vannucci F, Rossow S, and Marthaler DG
- Subjects
- Animals, Female, Longitudinal Studies, Minnesota, Picornaviridae Infections epidemiology, Picornaviridae Infections virology, Swine, Swine Diseases epidemiology, Vascular Diseases epidemiology, Vascular Diseases virology, Disease Outbreaks veterinary, Picornaviridae, Picornaviridae Infections veterinary, Swine Diseases virology, Vascular Diseases veterinary, Virus Shedding
- Abstract
Background: The study highlights the shedding pattern of Senecavirus A (SVA) during an outbreak of vesicular disease in a sow farm from the South-central Minnesota, USA. In this study, 34 individual, mixed parity sows with clinical signs of vesicular lesions and 30 individual piglets from 15 individual litters from sows with vesicular lesions were conveniently selected for individual, longitudinal sampling. Serum, tonsil, rectal, and vesicular swabs were collected on day1 post outbreak, and then again at 1, 2, 3, 4, 6, and 9 weeks post outbreak. Samples were tested at the University of Minnesota Veterinary Diagnostic Laboratory for SVA via Real Time Polymerase Chain Reaction (RT-PCR) RESULTS: In sows, vesicular lesions had the highest concentration of SVA, but had the shortest duration of detection lasting only 2 weeks. Viremia was detected for 1 week post outbreak, and quickly declined thereafter. SVA was detected at approximately the same frequency for both tonsil and rectal swabs with the highest percentage of SVA positive samples detected in the first 6 weeks post outbreak. In suckling piglets, viremia quickly declined 1 week post outbreak and was prevalent in low levels during the first week after weaning (4 weeks post outbreak) and was also detected in piglets that were co-mingled from a SVA negative sow farm. Similar to sows, SVA detection on rectal and tonsil swabs in piglets lasted approximately 6 weeks post outbreak., Conclusion: The study illustrates the variation of SVA shedding patterns in different sample types over a 9 week period in sows and piglets, and suggests the potential for viral spread between piglets at weaning.
- Published
- 2017
- Full Text
- View/download PDF
35. Herpes zoster ophthalmicus with associated vasculopathy causing stroke.
- Author
-
Antia C, Persad L, and Alikhan A
- Subjects
- Female, Humans, Middle Aged, Vascular Diseases diagnosis, Herpes Zoster Ophthalmicus virology, Herpesvirus 3, Human physiology, Stroke virology, Vascular Diseases virology, Virus Activation
- Abstract
Varicella zoster virus (VZV) is an exclusively human, double-stranded DNA virus. Primary infection causes varicella (chickenpox); later the virus becomes dormant in the dorsal root, cranial nerve, and autonomic ganglia along the entire span of the nervous system, retaining the capacity to reactivate and cause a variety of dermal and neurological complications. Recently there has been increasing recognition, both clinically and epidemiologically, of the relationship between VZV and subsequent strokes. Herein, we describe a case of a previously healthy individual with reactivation of VZV causing herpes zoster opthtalmicus along with devastating multifocal vasculopathy. It is crucial for dermatologists to recognize the dermatomal vesicular eruption in this high risk area to aid in prompt diagnosis in an effort to improve clinical prognosis.
- Published
- 2017
36. Adult post-varicella small vessel vaculopathy mimicking hypertensive basal ganglia hemorrhage with coexisting infarcts.
- Author
-
Harsha KJ and Parameswaran K
- Subjects
- Humans, Basal Ganglia Hemorrhage diagnosis, Chickenpox complications, Vascular Diseases virology
- Published
- 2016
- Full Text
- View/download PDF
37. Herpes zoster ophthalmicus and varicella zoster virus vasculopathy.
- Author
-
Bandeira F, Roizenblatt M, Levi GC, Freitas Dd, and Belfort R Jr
- Subjects
- Herpes Zoster Ophthalmicus complications, Herpes Zoster Ophthalmicus therapy, Humans, Risk Factors, Stroke complications, Stroke virology, Vascular Diseases complications, Herpes Zoster Ophthalmicus physiopathology, Herpesvirus 3, Human physiology, Vascular Diseases virology
- Abstract
Herpes zoster (HZ) corresponds to the reactivation of varicella zoster virus (VZV). Among adults, the ophthalmic division of the trigeminal nerve is one of the most common sites of involvement. Vasculopathy caused by HZ is associated with significant morbidity and mortality, affecting structures such as the brain, which can lead to stroke. In this review, we analyzed the epidemiological and clinical aspects of the vascular involvement of VZV, focusing on the peculiarities of its association with ocular HZ. A review of the available literature indicated that ocular involvement of HZ was a risk factor for vasculopathy after adjusting for age, sex, body mass index, smoking, indicators of metabolic syndrome, and vascular and heart diseases. Considering the severity of this complication, vascular disease mediated by VZV requires early diagnosis and aggressive treatment. Finally, the anti-HZ vaccine has been recommended as a prophylactic measure in the elderly, but it should be used with caution in immunocompromised individuals.
- Published
- 2016
- Full Text
- View/download PDF
38. Varicella-zoster virus vasculopathy in a 75-year-old immunocompetent man.
- Author
-
Artemiadis AK, Karantoni E, Nikolaou G, and Terentiou A
- Subjects
- Aged, Humans, Male, Immunocompetence, Varicella Zoster Virus Infection complications, Vascular Diseases virology
- Published
- 2016
- Full Text
- View/download PDF
39. Impact of Obliterative Portal Venopathy Associated With Human Immunodeficiency Virus.
- Author
-
Hollande C, Mallet V, Darbeda S, Vallet-Pichard A, Fontaine H, Verkarre V, Sogni P, Terris B, Gouya H, and Pol S
- Subjects
- Female, France epidemiology, Humans, Male, Middle Aged, Retrospective Studies, Vascular Diseases epidemiology, HIV Infections complications, Portal Vein, Vascular Diseases virology
- Abstract
HIV-associated obstructive portopathy (HIVOP) is an obstruction of the hepatic microvasculature of unknown origin. The purpose of this study was to describe the clinical and paraclinical presentation of the disease and its impact in terms of morbidity. Twenty-nine HIV1-infected patients (average 12 years of infection, nadir of CD4 210/mm, including 7 patients with a history of opportunistic infection) with a biopsy-proven or likely HIVOP have been followed up for an average of 6.1 years. Modes of revelation of the HIVOP were: cytolysis and/or cholestasis (60%), occult (14%) or symptomatic (37%) portal hypertension (esophageal varices 17%, ascites 10%, cytopenia 10%), or fortuitous (8%). Hypoalbuminemia (≤35 g/L) was present in (31%), thrombocytopenia (<150,000 platelets) in 52% and prothrombin rate <70% in 10%. Esophageal varices were detected in 71%. Thrombophilia was present in 23 patients (80%): in head, protein S deficiency (87%). MRI showed in 82% at least 1 morphological abnormality. The average value of the liver stiffness by Fibroscan was 8.3 kPa. During follow-up, there was no radiological improvement, 15 (52%) patients presented with variceal hemorrhage, 10 patients (34%) ascites, 10 (34%) portal vein thrombosis, 7 (24%) an iron deficiency, and 2 (7%) with a protein-losing enteropathy, including 14 patients (48%) with several events. Four patients (14%) were transplanted, 1 (25%) recurred the HIVOP on the graft, and 1 patient is waiting for a transplant. HIVOP is a severe disease associated with high morbidity related to symptomatic portal hypertension, which occurred in 50% and required liver transplantation in 14%.
- Published
- 2016
- Full Text
- View/download PDF
40. Varicella zoster virus vasculopathy in suspected giant cell arteritis.
- Author
-
Levin MH
- Subjects
- Female, Humans, Male, Giant Cell Arteritis pathology, Giant Cell Arteritis virology, Herpes Zoster diagnosis, Herpesvirus 3, Human pathogenicity, Temporal Arteries pathology, Temporal Arteries virology, Vascular Diseases pathology, Vascular Diseases virology
- Published
- 2014
- Full Text
- View/download PDF
41. Type I interferon is a therapeutic target for virus-induced lethal vascular damage.
- Author
-
Baccala R, Welch MJ, Gonzalez-Quintial R, Walsh KB, Teijaro JR, Nguyen A, Ng CT, Sullivan BM, Zarpellon A, Ruggeri ZM, de la Torre JC, Theofilopoulos AN, and Oldstone MB
- Subjects
- Animals, Bronchoalveolar Lavage, Cell Line, Cricetinae, Cytokines metabolism, Female, Lassa virus, Lymphocytic Choriomeningitis virology, Lymphocytic choriomeningitis virus metabolism, Male, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Inbred NZB, Mice, Transgenic, Signal Transduction, Stem Cells chemistry, T-Lymphocytes, Cytotoxic virology, Virus Activation, Interferon Type I metabolism, Lassa Fever virology, Vascular Diseases virology
- Abstract
The outcome of a viral infection reflects the balance between virus virulence and host susceptibility. The clone 13 (Cl13) variant of lymphocytic choriomeningitis virus--a prototype of Old World arenaviruses closely related to Lassa fever virus--elicits in C57BL/6 and BALB/c mice abundant negative immunoregulatory molecules, associated with T-cell exhaustion, negligible T-cell-mediated injury, and high virus titers that persist. Conversely, here we report that in NZB mice, despite the efficient induction of immunoregulatory molecules and high viremia, Cl13 generated a robust cytotoxic T-cell response, resulting in thrombocytopenia, pulmonary endothelial cell loss, vascular leakage, and death within 6-8 d. These pathogenic events required type I IFN (IFN-I) signaling on nonhematopoietic cells and were completely abrogated by IFN-I receptor blockade. Thus, IFN-I may play a prominent role in hemorrhagic fevers and other acute virus infections associated with severe vascular pathology, and targeting IFN-I or downstream effector molecules may be an effective therapeutic approach.
- Published
- 2014
- Full Text
- View/download PDF
42. A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology.
- Author
-
Terrazzini N, Bajwa M, Vita S, Cheek E, Thomas D, Seddiki N, Smith H, and Kern F
- Subjects
- Adult, Age Factors, Aged, Aged, 80 and over, Antigens, CD immunology, Blood Pressure immunology, Cytomegalovirus Infections blood, Cytomegalovirus Infections physiopathology, Female, Humans, Male, Middle Aged, T-Lymphocytes, Regulatory chemistry, Vascular Diseases blood, Vascular Diseases immunology, Vascular Diseases physiopathology, Young Adult, Cytomegalovirus immunology, Cytomegalovirus Infections immunology, T-Lymphocyte Subsets immunology, T-Lymphocytes, Regulatory immunology, Vascular Diseases virology
- Abstract
Background: Cytomegalovirus (CMV) infection directly targets vascular endothelium and smooth muscle and at older ages is associated with accelerated vascular pathology and mortality. CMV-specific cellular immunity might directly contribute to this process., Methods: Conventional ex vivo activation-induced T-cell responses to 19 dominant CMV antigens, along with CMV-specific inducible regulatory-type CD4+ T cells (iTregs), were measured in healthy older people, using a novel protocol that included classic Treg markers alongside the activation marker CD134. Measurements were correlated with diastolic, systolic, and mean arterial blood pressure, a surrogate marker for arterial stiffness., Results: CMV-specific iTregs recognized the same antigens as conventional CD4+ T cells and were significantly more frequent at older ages. They suppressed antigen-specific and nonspecific proliferation and in large part expressed Foxp3. Frequencies of CMV-specific iTregs and CD8+ T cells (summated response) were significantly associated with diastolic and mean arterial pressures. Confounders, including age, body mass index, smoking, antihypertensive medication use, or C-reactive protein levels, did not explain these observations., Conclusions: A novel CMV-induced regulatory-type CD4+ T-cell subset is readily detectable in CMV-infected people and, like the aggregate CD8+ T-cell response to the most dominant CMV antigens, is quantitatively associated with arterial stiffness in older life. Whereas CD8+ effector T cells might directly cause vascular injury, iTregs may attenuate this response.
- Published
- 2014
- Full Text
- View/download PDF
43. Leg paralysis due to herpes zoster: segmental paralysis or viral vasculopathy and stroke?
- Author
-
Chernev I and Dado D
- Subjects
- Humans, Leg, Herpes Zoster complications, Paralysis virology, Stroke virology, Vascular Diseases virology
- Published
- 2014
- Full Text
- View/download PDF
44. Potential role of proinflammatory cytokines in the pathogenetic mechanisms of vascular lesions in goats naturally infected with bluetongue virus serotype 1.
- Author
-
Sánchez-Cordón PJ, Pedrera M, Risalde MA, Molina V, Rodríguez-Sánchez B, Núñez A, Sánchez-Vizcaíno JM, and Gómez-Villamandos JC
- Subjects
- Animals, Bluetongue complications, Bluetongue pathology, Bluetongue virus genetics, Cell Membrane Permeability, Edema etiology, Edema metabolism, Enzyme-Linked Immunosorbent Assay, Goats, Hemorrhage etiology, Hemorrhage metabolism, Immunoenzyme Techniques, Inflammation Mediators metabolism, Interleukin-1alpha genetics, RNA, Messenger genetics, RNA, Viral genetics, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Tumor Necrosis Factor-alpha genetics, Vascular Diseases immunology, Vascular Diseases virology, Bluetongue immunology, Bluetongue virus pathogenicity, Interleukin-1alpha metabolism, Tumor Necrosis Factor-alpha metabolism, Vascular Diseases pathology
- Abstract
In vitro studies have demonstrated that bluetongue virus (BTV)-induced vasoactive mediators could contribute to the endothelial cells dysfunction and increased vascular permeability responsible of lesions characteristic of bluetongue (BT) like oedema, haemorrhages and ischaemic necrosis in different tissues. However, few in vivo studies have been carried out to clarify the causes of these lesions. The aim of this study was to elucidate in vivo the pathogenetic mechanisms involved in the appearance of vascular lesions in different organs during BT. For this purpose, tissue samples from goats naturally infected with bluetongue virus serotype 1 (BTV-1) were taken for histopathological and immunohistochemical studies to determine the potential role of proinflammatory cytokines (tumour necrosis factor alpha, TNFα and interleukin one alpha, IL-1α) in the increased vascular permeability and their relationship with the presence of virus. Gross and histopathological examination revealed the presence of vascular damage leading to generalized oedema and haemorrhages. Immunohistochemical studies displayed that endothelial injury may have been due to the direct pathogenic effect of BTV infection on endothelial cells or may be a response to inflammatory mediators released by virus-infected endothelial cells and, possibly, other cell types such as monocytes/macrophages. These preliminary results of what appears to be the first in vivo study of tissue damage in small BT-infected ruminants suggest a direct link between the appearance of vascular changes and the presence of BTV-induced vasoactive cytokines., (© Her Majesty the Queen in Right of Canada 2012. Reproduced with the permission of the Minister of Canadian Food Inspection Agency.)
- Published
- 2013
- Full Text
- View/download PDF
45. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis.
- Author
-
Nagel MA, Bennett JL, Khmeleva N, Choe A, Rempel A, Boyer PJ, and Gilden D
- Subjects
- Adult, Diagnosis, Differential, Female, Giant Cell Arteritis diagnosis, Herpes Zoster epidemiology, Herpes Zoster pathology, Humans, Incidence, Inflammation diagnosis, Inflammation pathology, Inflammation virology, Male, Middle Aged, Vascular Diseases diagnosis, Giant Cell Arteritis pathology, Giant Cell Arteritis virology, Herpes Zoster diagnosis, Herpesvirus 3, Human pathogenicity, Temporal Arteries pathology, Temporal Arteries virology, Vascular Diseases pathology, Vascular Diseases virology
- Abstract
Objective: To address the incidence of varicella-zoster virus (VZV) infection in patients with biopsy-negative giant cell arteritis (GCA), we examined archived biopsy-negative temporal arteries from subjects with clinically suspected GCA for the presence of VZV antigen., Methods: Formalin-fixed, paraffin-embedded temporal arteries that were pathologically negative for GCA and normal temporal arteries were analyzed immunohistochemically for VZV and herpes simplex virus-1 (HSV-1) antigen., Results: Five (21%) of 24 temporal arteries from patients who were clinically suspect but biopsy negative for GCA revealed VZV but not HSV-1 by immunohistochemical analysis. Thirteen normal temporal arteries did not contain VZV or HSV-1 antigen. All 5 subjects whose temporal arteries contained VZV antigen presented with clinical and laboratory features of GCA and early visual disturbances., Conclusion: Multifocal VZV vasculopathy can present with the full spectrum of clinical features and laboratory abnormalities characteristically seen in GCA.
- Published
- 2013
- Full Text
- View/download PDF
46. Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.
- Author
-
Nagel MA, Traktinskiy I, Stenmark KR, Frid MG, Choe A, and Gilden D
- Subjects
- Adult, Adventitia immunology, Aged, Aged, 80 and over, B-Lymphocytes immunology, Case-Control Studies, Female, Humans, Inflammation immunology, Inflammation pathology, Inflammation virology, Macrophages immunology, Male, Middle Aged, Middle Cerebral Artery pathology, Middle Cerebral Artery virology, Neutrophils immunology, T-Lymphocytes immunology, Temporal Arteries pathology, Temporal Arteries virology, Tunica Intima immunology, Tunica Intima pathology, Vascular Diseases pathology, Vascular Diseases virology, Virus Diseases pathology, Virus Diseases virology, Herpesvirus 3, Human immunology, Middle Cerebral Artery immunology, Temporal Arteries immunology, Vascular Diseases immunology, Virus Diseases immunology
- Abstract
Objective: Pathologic changes in varicella-zoster virus (VZV)-infected arteries include inflammation, thickened intima, and paucity of smooth muscle cells. Since no criteria have been established for early vs late VZV vasculopathy, we examined inflammatory cells and their distribution in 6 normal arteries, and 2 VZV-infected arteries 3 days after onset of disease (early) and 10 months after protracted neurologic disease (late)., Methods: VZV-infected temporal artery obtained 3 days after onset of ischemic optic neuropathy from an 80-year-old man, VZV-infected middle cerebral artery (MCA) obtained 10 months after protracted disease from a 73-year-old man, and 5 MCAs and 1 temporal artery from normal subjects, age 22-60 years, were examined histologically and immunohistochemically using antibodies against VZV and inflammatory cell subsets., Results: In both early and late VZV vasculopathy, T cells, activated macrophages, and rare B cells were found in adventitia and intima. In adventitia of early VZV vasculopathy, neutrophils and VZV antigen were abundant and a thickened intima was associated with inflammatory cells in vaso vasorum vessels. In media of late VZV vasculopathy, viral antigen, but not leukocytes, was found. VZV was not seen in inflammatory cells. Inflammatory cells were absent in control arteries., Conclusions: Both VZV and neutrophils exclusively in adventitia in early VZV vasculopathy indicate that disease begins there. Late VZV vasculopathy is distinguished by viral antigen without inflammation in media, revealing a human virus in an immunoprivileged arterial media. Association of thickened intima and inflammation in vaso vasorum vessels in early VZV vasculopathy support the role of virus-induced inflammation in vessel wall remodeling.
- Published
- 2013
- Full Text
- View/download PDF
47. Influence of mast cells on dengue protective immunity and immune pathology.
- Author
-
St John AL
- Subjects
- Animals, Dengue complications, Dengue Virus immunology, Humans, Immune System Diseases virology, Immunologic Memory, Immunologic Surveillance physiology, Severe Dengue immunology, Vascular Diseases etiology, Vascular Diseases immunology, Vascular Diseases virology, Dengue immunology, Immune System Diseases immunology, Immunity, Active, Mast Cells immunology
- Published
- 2013
- Full Text
- View/download PDF
48. Cytomegalovirus CC chemokine promotes immune cell migration.
- Author
-
Vomaske J, Denton M, Kreklywich C, Andoh T, Osborn JM, Chen D, Messaoudi I, Orloff SL, and Streblow DN
- Subjects
- Animals, Chemokines, CC genetics, Chemokines, CC metabolism, DNA Mutational Analysis, Disease Models, Animal, Heart Transplantation adverse effects, Herpesviridae Infections complications, Herpesviridae Infections pathology, Herpesviridae Infections virology, Male, Muromegalovirus genetics, Mutant Proteins genetics, Mutant Proteins immunology, Mutant Proteins metabolism, Protein Binding, Rats, Receptors, CCR metabolism, Sclerosis immunology, Sclerosis pathology, Sclerosis virology, Vascular Diseases immunology, Vascular Diseases pathology, Vascular Diseases virology, Viral Proteins genetics, Viral Proteins immunology, Viral Proteins metabolism, Virulence Factors genetics, CD4-Positive T-Lymphocytes immunology, Cell Movement, Chemokines, CC immunology, Muromegalovirus immunology, Muromegalovirus pathogenicity, Virulence Factors immunology, Virulence Factors metabolism
- Abstract
Cytomegaloviruses manipulate the host chemokine/receptor axis by altering cellular chemokine expression and by encoding multiple chemokines and chemokine receptors. Similar to human cytomegalovirus (HCMV), rat cytomegalovirus (RCMV) encodes multiple CC chemokine-analogous proteins, including r129 (HCMV UL128 homologue) and r131 (HCMV UL130 and MCMV m129/130 homologues). Although these proteins play a role in CMV entry, their function as chemotactic cytokines remains unknown. In the current study, we examined the role of the RCMV chemokine r129 in promoting cellular migration and in accelerating transplant vascular sclerosis (TVS) in our rat heart transplant model. We determined that r129 protein is released into culture supernatants of infected cells and is expressed with late viral gene kinetics during RCMV infection and highly expressed in heart and salivary glands during in vivo rat infections. Using the recombinant r129 protein, we demonstrated that r129 induces migration of lymphocytes isolated from rat peripheral blood, spleen, and bone marrow and from a rat macrophage cell line. Using antibody-mediated cell sorting of rat splenocytes, we demonstrated that r129 induces migration of naïve/central memory CD4(+) T cells. Through ligand-binding assays, we determined that r129 binds rat CC chemokine receptors CCR3, CCR4, CCR5, and CCR7. In addition, mutational analyses identified functional domains of r129 resulting in recombinant proteins that fail to induce migration (r129-ΔNT and -C31A) or alter the chemotactic ability of the chemokine (r129-F43A). Two of the mutant proteins (r129-C31A and -ΔNT) also act as dominant negatives by inhibiting migration induced by wild-type r129. Furthermore, infection of rat heart transplant recipients with RCMV containing the r129-ΔNT mutation prevented CMV-induced acceleration of TVS. Together our findings indicate that RCMV r129 is highly chemotactic, which has important implications during RCMV infection and reactivation and acceleration of TVS.
- Published
- 2012
- Full Text
- View/download PDF
49. Cytomegalovirus-induced cutaneous microangiopathy manifesting as lower limb ischemia in a human immunodeficiency virus-infected patient.
- Author
-
Molina-Ruiz AM, Luque R, Zulueta T, Bernabeu J, and Requena L
- Subjects
- AIDS-Related Opportunistic Infections immunology, AIDS-Related Opportunistic Infections pathology, Adult, Cytomegalovirus Infections immunology, Cytomegalovirus Infections pathology, Female, Humans, Ischemia pathology, Leg blood supply, Skin Diseases, Infectious pathology, Skin Diseases, Infectious virology, Vascular Diseases immunology, Vascular Diseases pathology, Vascular Diseases virology, AIDS-Related Opportunistic Infections complications, Cytomegalovirus Infections complications, HIV Infections complications, Immunocompromised Host, Ischemia virology
- Abstract
Cutaneous infections by cytomegalovirus (CMV) are rare and often difficult to diagnose both clinically and histopathologically. A wide range of different clinical manifestations have been described in the literature, especially in immunosuppressed patients. CMV-induced thrombosis has also been reported in these patients, and various mechanisms have been proposed to explain the role of CMV in the thrombotic process, including direct damage of the endothelial cells, activation of coagulation factors and inducing the production of antiphospholipid antibodies. We present the case of a human immunodeficiency virus (HIV)-infected woman who developed distal ischemic lesions of the lower extremities during a generalized CMV infection. We discuss the role of CMV and antiphospholipid antibodies in the pathogenesis of thrombosis in immunosuppressed patients., (Copyright © 2012 John Wiley & Sons A/S.)
- Published
- 2012
- Full Text
- View/download PDF
50. Extensive extracranial and intracranial Varicella zoster vasculopathy.
- Author
-
Verma R, Lalla R, and Patil TB
- Subjects
- Adult, Brain pathology, Carotid Artery Diseases diagnosis, Carotid Artery Diseases pathology, Carotid Artery Diseases virology, Diagnosis, Differential, Herpes Zoster diagnosis, Humans, Magnetic Resonance Imaging, Male, Neuroimaging, Vascular Diseases diagnosis, Vascular Diseases pathology, Herpes Zoster pathology, Vascular Diseases virology
- Abstract
Varicella zoster virus (VZV)-induced vasculopathy is an uncommon cause of stroke in a young immunocompetent host. Owing to scarcity of data of VZV-induced vasculopathy and lack of awareness about this condition and its diagnostic test, these cases may be easily missed. In this case, we report an immunocompetent host presenting right-side hemiplegia with motor aphasia and complete loss of vision in the left eye due to complete occlusion of the left common carotid artery without any history of skin rash preceding stroke. Cerebrospinal fluid analysis for varicella antibody revealed very high titres and CT aortogram demonstrated aortoarteritis with occlusion of left common carotid artery. To our knowledge, varicella zoster vasculopathy-associated aortoarteritis has not been described in the literature.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.